Anesiva's media center is designed to provide reporters with easy access to news about the company and its products for stories in development. If you don't find what you are looking for or need more information, please contact us.
| All Releases |
|---|
 |
Corgentech to Present at Needham Third Annual Biotechnology Conference
Jun 10, 2004
|
66.9 KB
|
| |
SOUTH SAN FRANCISCO, Calif., Jun 10, 2004 /PRNewswire-FirstCall via COMTEX/ -- Corgentech Inc. (Nasdaq: CGTK), a biotechnology company, today announced that Richard P. Powers, the company's vice president and chief financial officer, will present at the Needham Third Annual Biotechnology Conference on Wednesday June 16, 2004 at 2:00 p.m. EDT at t...
|
|
|
Corgentech to Present at UBS 2004 Global Specialty Pharmaceuticals Conference
May 21, 2004
|
68.0 KB
|
| |
SOUTH SAN FRANCISCO, Calif., May 21, 2004 /PRNewswire-FirstCall via COMTEX/ -- Corgentech Inc. (Nasdaq: CGTK), a biotechnology company, today announced that John McLaughlin, the company's president and chief executive officer, will present at the UBS 2004 Global Specialty Pharmaceuticals Conference on Tuesday, May 25, 2004 at 4:30 p.m. EDT at the...
|
|
|
Corgentech Begins Phase I/II Trial of E2F Decoy for Prevention of AV Graft Failure in Patients With End-Stage Renal Disease
May 18, 2004
|
73.2 KB
|
| |
SOUTH SAN FRANCISCO, Calif., May 18, 2004 /PRNewswire-FirstCall via COMTEX/ -- Corgentech Inc., (Nasdaq: CGTK), a biotechnology company, today announced that patient enrollment has begun in the Phase I/II study of E2F Decoy (edifoligide) for the prevention of arterio-venous (AV) graft failure in patients with end-stage renal disease who require h...
|
|
|
Corgentech Announces New Centers for Medicare & Medicaid Services Procedure Code May Apply to E2F Decoy
May 14, 2004
|
71.5 KB
|
| |
SOUTH SAN FRANCISCO, Calif., May 14, 2004 /PRNewswire-FirstCall via COMTEX/ -- Corgentech Inc. (Nasdaq: CGTK), a biotechnology company, today announced that the Centers for Medicare & Medicaid Services (CMS), a Federal agency within the U.S. Department of Health and Human Services, has published a new ICD-9-CM procedure code for "pressurized trea...
|
|
|
Corgentech to Present at Deutsche Bank's 29th Annual Health Care Conference
Apr 30, 2004
|
67.6 KB
|
| |
SOUTH SAN FRANCISCO, Calif., Apr 30, 2004 /PRNewswire-FirstCall via COMTEX/ -- Corgentech Inc. (Nasdaq: CGTK), a biotechnology company, today announced that John McLaughlin, the company's president and chief executive officer, will present at Deutsche Bank's 29th Annual Health Care Conference. The five-minute presentation, followed by a 20-minut...
|
|
|
Click here to download our most recent fact sheet.